We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cultured Liver Cells Now Available for Research Applications

By LabMedica International staff writers
Posted on 08 Dec 2015
Print article
Image: Polarized fluorescent micrograph showing hepatocytes generated by the upcyte technique (Photo courtesy of Dr. Yaakov Nahmias, Hebrew University of Jerusalem, Israel).
Image: Polarized fluorescent micrograph showing hepatocytes generated by the upcyte technique (Photo courtesy of Dr. Yaakov Nahmias, Hebrew University of Jerusalem, Israel).
An advance in cell culture technology will enable researchers to maintain liver cells (hepatocytes) in culture for up to 40 replication cycles, which will provide important study material for research, clinical applications, and pharmaceutical development.

Hepatocytes have a critical role in the metabolism of an organism, but their study is limited by the inability to expand primary hepatocytes in vitro while maintaining proliferative capacity and metabolic function. Heretofore, attempts to expand human hepatocytes in the laboratory have generated immortalized cancer cells with little metabolic function.

Recently, investigators at the Hebrew University of Jerusalem (Israel) and their colleagues at the biotechnology company upcyte technologies GmbH (Hamburg, Germany) described a process for growing in vitro cultures of human hepatocytes.

They reported in the October 26, 2015, online edition of the journal Nature Biotechnology that weak expression of the E6 and E7 genes from human papilloma virus (HPV) released hepatocytes from cell-cycle arrest and allowed them to proliferate in response to stimulation by Oncostatin M (OSM), a member of the interleukin 6 (IL-6) super family of cytokines, which is involved in liver regeneration. This procedure has been dubbed the "upcyte" technique.

Stimulation of cultures with OSM according to the upcyte procedure caused cell proliferation, with doubling time of 33 to 49 hours. Removal of OSM then caused growth arrest and hepatic differentiation within four days, generating populations of 1013 to 1016 highly functional liver cells from a single human hepatocyte isolate.

Differentiated hepatocytes showed transcriptional and toxicity profiles and cytochrome P450 induction similar to those of primary human hepatocytes. Replication and infectivity of Hepatitis C virus (HCV) in differentiated hepatocytes were similar to those of Huh7.5.1 human hepatoma cells.

“The approach is revolutionary,” said contributing author Dr. Joris Braspenning, CSO of upcyte technologies GmbH. “Its strength lies in our ability to generate liver cells from multiple donors, enabling the study of patient-to-patient variability and idiosyncratic toxicity.”

“This is the holy grail of liver research,” said senior author Dr. Yaakov Nahmias, professor of bioengineering at the Hebrew University of Jerusalem. “Our technology will enable thousands of laboratories to study fatty liver disease, viral hepatitis, drug toxicity, and liver cancer at a fraction of the current cost. Genetic modifications preclude using the cells for transplantation, but we may have found the perfect cell source for the bio-artificial liver project.”

Related Links:

Hebrew University of Jerusalem 
upcyte technologies GmbH


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.